IBDEI077 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17540,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,17540,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,17540,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,17541,0)
 ;;=N11.9^^65^766^98
 ;;^UTILITY(U,$J,358.3,17541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17541,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,17541,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,17541,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,17542,0)
 ;;=N20.9^^65^766^116
 ;;^UTILITY(U,$J,358.3,17542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17542,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,17542,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,17542,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,17543,0)
 ;;=R97.20^^65^766^29
 ;;^UTILITY(U,$J,358.3,17543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17543,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,17543,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,17543,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,17544,0)
 ;;=N52.36^^65^766^34
 ;;^UTILITY(U,$J,358.3,17544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17544,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,17544,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,17544,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,17545,0)
 ;;=N52.37^^65^766^35
 ;;^UTILITY(U,$J,358.3,17545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17545,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,17545,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,17545,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,17546,0)
 ;;=N52.35^^65^766^36
 ;;^UTILITY(U,$J,358.3,17546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17546,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,17546,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,17546,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,17547,0)
 ;;=R31.21^^65^766^56
 ;;^UTILITY(U,$J,358.3,17547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17547,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,17547,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,17547,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,17548,0)
 ;;=R31.29^^65^766^57
 ;;^UTILITY(U,$J,358.3,17548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17548,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,17548,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,17548,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,17549,0)
 ;;=R39.198^^65^766^70
 ;;^UTILITY(U,$J,358.3,17549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17549,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,17549,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,17549,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,17550,0)
 ;;=R39.191^^65^766^72
 ;;^UTILITY(U,$J,358.3,17550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17550,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,17550,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,17550,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,17551,0)
 ;;=R39.192^^65^766^71
 ;;^UTILITY(U,$J,358.3,17551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17551,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,17551,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,17551,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,17552,0)
 ;;=R97.21^^65^766^101
 ;;^UTILITY(U,$J,358.3,17552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17552,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,17552,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,17552,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,17553,0)
 ;;=N50.82^^65^766^102
 ;;^UTILITY(U,$J,358.3,17553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17553,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,17553,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,17553,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,17554,0)
 ;;=N50.812^^65^766^106
 ;;^UTILITY(U,$J,358.3,17554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17554,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,17554,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,17554,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,17555,0)
 ;;=N50.811^^65^766^107
 ;;^UTILITY(U,$J,358.3,17555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17555,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,17555,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,17555,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,17556,0)
 ;;=N35.919^^65^766^112
 ;;^UTILITY(U,$J,358.3,17556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17556,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,17556,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,17556,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,17557,0)
 ;;=N35.92^^65^766^111
 ;;^UTILITY(U,$J,358.3,17557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17557,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,17557,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,17557,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,17558,0)
 ;;=R82.81^^65^766^99
 ;;^UTILITY(U,$J,358.3,17558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17558,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,17558,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,17558,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,17559,0)
 ;;=R51.^^65^767^2
 ;;^UTILITY(U,$J,358.3,17559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17559,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,17559,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,17559,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,17560,0)
 ;;=G44.1^^65^767^9
 ;;^UTILITY(U,$J,358.3,17560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17560,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,17560,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,17560,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,17561,0)
 ;;=G43.909^^65^767^5
 ;;^UTILITY(U,$J,358.3,17561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17561,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,17561,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,17561,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,17562,0)
 ;;=G44.009^^65^767^1
 ;;^UTILITY(U,$J,358.3,17562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17562,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,17562,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,17562,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,17563,0)
 ;;=G44.40^^65^767^4
 ;;^UTILITY(U,$J,358.3,17563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17563,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,17563,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,17563,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,17564,0)
 ;;=G44.89^^65^767^3
 ;;^UTILITY(U,$J,358.3,17564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17564,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,17564,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,17564,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,17565,0)
 ;;=G44.84^^65^767^7
 ;;^UTILITY(U,$J,358.3,17565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17565,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,17565,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,17565,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,17566,0)
 ;;=G44.301^^65^767^6
 ;;^UTILITY(U,$J,358.3,17566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17566,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,17566,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,17566,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,17567,0)
 ;;=G44.209^^65^767^8
 ;;^UTILITY(U,$J,358.3,17567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17567,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,17567,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,17567,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,17568,0)
 ;;=I30.0^^65^768^5
 ;;^UTILITY(U,$J,358.3,17568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17568,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,17568,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,17568,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,17569,0)
 ;;=I34.8^^65^768^6
 ;;^UTILITY(U,$J,358.3,17569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17569,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,17569,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,17569,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,17570,0)
 ;;=I34.0^^65^768^13
 ;;^UTILITY(U,$J,358.3,17570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17570,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,17570,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,17570,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,17571,0)
 ;;=I34.9^^65^768^12
 ;;^UTILITY(U,$J,358.3,17571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17571,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,17571,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,17571,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,17572,0)
 ;;=I34.2^^65^768^7
 ;;^UTILITY(U,$J,358.3,17572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17572,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,17572,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,17572,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,17573,0)
 ;;=I35.0^^65^768^10
 ;;^UTILITY(U,$J,358.3,17573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17573,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,17573,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,17573,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,17574,0)
 ;;=I35.1^^65^768^9
 ;;^UTILITY(U,$J,358.3,17574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17574,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,17574,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,17574,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,17575,0)
 ;;=I35.2^^65^768^11
 ;;^UTILITY(U,$J,358.3,17575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17575,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,17575,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,17575,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,17576,0)
 ;;=I35.9^^65^768^8
 ;;^UTILITY(U,$J,358.3,17576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17576,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,17576,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,17576,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,17577,0)
 ;;=I38.^^65^768^4
 ;;^UTILITY(U,$J,358.3,17577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17577,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,17577,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,17577,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,17578,0)
 ;;=I05.0^^65^768^18
 ;;^UTILITY(U,$J,358.3,17578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17578,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,17578,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,17578,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,17579,0)
 ;;=I05.8^^65^768^19
 ;;^UTILITY(U,$J,358.3,17579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17579,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,17579,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,17579,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,17580,0)
 ;;=I05.9^^65^768^20
 ;;^UTILITY(U,$J,358.3,17580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17580,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,17580,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,17580,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,17581,0)
 ;;=I07.1^^65^768^21
 ;;^UTILITY(U,$J,358.3,17581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17581,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,17581,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,17581,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,17582,0)
 ;;=I07.9^^65^768^22
 ;;^UTILITY(U,$J,358.3,17582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17582,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,17582,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,17582,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,17583,0)
 ;;=I08.0^^65^768^16
 ;;^UTILITY(U,$J,358.3,17583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17583,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,17583,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,17583,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,17584,0)
 ;;=I09.89^^65^768^17
 ;;^UTILITY(U,$J,358.3,17584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17584,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,17584,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,17584,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,17585,0)
 ;;=I47.1^^65^768^24
 ;;^UTILITY(U,$J,358.3,17585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17585,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,17585,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,17585,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,17586,0)
 ;;=I48.0^^65^768^15
 ;;^UTILITY(U,$J,358.3,17586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17586,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,17586,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,17586,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,17587,0)
 ;;=I49.5^^65^768^23
 ;;^UTILITY(U,$J,358.3,17587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17587,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,17587,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,17587,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,17588,0)
 ;;=I49.8^^65^768^3
 ;;^UTILITY(U,$J,358.3,17588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17588,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,17588,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,17588,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,17589,0)
 ;;=I49.9^^65^768^2
 ;;^UTILITY(U,$J,358.3,17589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17589,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,17589,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,17589,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,17590,0)
 ;;=R00.1^^65^768^1
 ;;^UTILITY(U,$J,358.3,17590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17590,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,17590,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,17590,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,17591,0)
 ;;=I34.1^^65^768^14
 ;;^UTILITY(U,$J,358.3,17591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17591,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,17591,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,17591,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,17592,0)
 ;;=D68.4^^65^769^1
 ;;^UTILITY(U,$J,358.3,17592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17592,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,17592,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,17592,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,17593,0)
 ;;=D59.9^^65^769^2
 ;;^UTILITY(U,$J,358.3,17593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17593,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,17593,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,17593,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,17594,0)
 ;;=C91.00^^65^769^5
 ;;^UTILITY(U,$J,358.3,17594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17594,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,17594,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,17594,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,17595,0)
 ;;=C91.01^^65^769^4
 ;;^UTILITY(U,$J,358.3,17595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17595,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,17595,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,17595,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,17596,0)
 ;;=C92.01^^65^769^7
 ;;^UTILITY(U,$J,358.3,17596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17596,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,17596,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,17596,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,17597,0)
 ;;=C92.00^^65^769^8
 ;;^UTILITY(U,$J,358.3,17597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17597,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,17597,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,17597,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,17598,0)
 ;;=C92.61^^65^769^9
 ;;^UTILITY(U,$J,358.3,17598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17598,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,17598,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,17598,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,17599,0)
 ;;=C92.60^^65^769^10
 ;;^UTILITY(U,$J,358.3,17599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17599,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,17599,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,17599,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,17600,0)
 ;;=C92.A1^^65^769^11
 ;;^UTILITY(U,$J,358.3,17600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17600,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,17600,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,17600,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,17601,0)
 ;;=C92.A0^^65^769^12
 ;;^UTILITY(U,$J,358.3,17601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17601,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,17601,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,17601,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,17602,0)
 ;;=C92.51^^65^769^13
 ;;^UTILITY(U,$J,358.3,17602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17602,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,17602,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,17602,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,17603,0)
 ;;=C92.50^^65^769^14
 ;;^UTILITY(U,$J,358.3,17603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17603,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,17603,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,17603,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,17604,0)
 ;;=C94.40^^65^769^17
 ;;^UTILITY(U,$J,358.3,17604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17604,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,17604,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,17604,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,17605,0)
 ;;=C94.42^^65^769^15
 ;;^UTILITY(U,$J,358.3,17605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17605,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,17605,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,17605,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,17606,0)
 ;;=C94.41^^65^769^16
 ;;^UTILITY(U,$J,358.3,17606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17606,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,17606,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,17606,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,17607,0)
 ;;=D62.^^65^769^18
 ;;^UTILITY(U,$J,358.3,17607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17607,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,17607,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,17607,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,17608,0)
 ;;=C92.41^^65^769^19
 ;;^UTILITY(U,$J,358.3,17608,1,0)
 ;;=^358.31IA^4^2
